Search results
Results from the WOW.Com Content Network
Volume growth from Amgen's (AMGN) key drugs like Prolia, Xgeva, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.
For premium support please call: 800-290-4726 more ways to reach us
[3] [4] As one of the world's largest independent biotechnology companies, Amgen has approximately 24,000 staff in total as of 2022. [ 5 ] The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics, which became the official name of the company in 1983 (three years after incorporation and coincident with its ...
Lilly recorded a total of $2 billion from its GLP-1 products in 2023, while Novo Nordisk pocketed $18.4 billion in the same period. Both companies have said that demand continues to outstrip supply.
Maridebart cafraglutide (also known as MariTide; [1] developmental name AMG 133) is an investigational drug developed by Amgen for the treatment of obesity.It is an agonist of the GLP-1 receptor (GLP-1R) and an antagonist of the glucose-dependent insulinotropic polypeptide receptor (GIPR).
Epoetin alfa, sold under the brand name Epogen among others, is a human erythropoietin produced in cell culture using recombinant DNA technology. [8] [9] Epoetin alfa is an erythropoiesis-stimulating agent. [8]
With a late-stage clinical pipeline running smoothly and strong growth in 2023 of its key market drivers, Amgen is eyeing annual revenue of $32.4 billion on the low end and up to $33.8 billion for ...
2023-1-23 The effective date of an award of service-related disability compensation to a veteran of the United States military determined pursuant to 38 U.S.C. §§5110(a)(1) and 5110(b)(1) is not subject to equitable tolling. In re Grand Jury: 21-1397: 2023-1-23 Certiorari dismissed as improvidently granted. Cruz v. Arizona: 21-846: 2023-2-22